ONCYInvestor Events•prnewswire•August 28, 2025 at 12:30 PM

Oncolytics Biotech® Announces Upcoming Investor Conferences in September

Sentiment:Negative (35)

Summary

SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, will participate in two investor conferences next month. CEO Jared Kelly will be meeting with institutional...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 28, 2025 by prnewswire